A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains.
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Etodolac; Etodolac/lidocaine; Lidocaine
- Indications Musculoskeletal pain; Sprains
- Focus Therapeutic Use
- Sponsors MEDRx
- 14 Nov 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2010 New trial record